Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts : contribution to the increase of tumor-promoting IL-6 in colon cancer
© 2022. The Author(s), under exclusive licence to Springer Nature Limited..
BACKGROUND: Increases in IL-6 by cancer-associated fibroblasts (CAFs) contribute to colon cancer progression, but the mechanisms involved in the increase of this tumor-promoting cytokine are unknown. The aim of this study was to identify novel targets involved in the dysregulation of IL-6 expression by CAFs in colon cancer.
METHODS: Colonic normal (N), hyperplastic, tubular adenoma, adenocarcinoma tissues, and tissue-derived myo-/fibroblasts (MFs) were used in these studies.
RESULTS: Transcriptomic analysis demonstrated a striking decrease in alcohol dehydrogenase 1B (ADH1B) expression, a gene potentially involved in IL-6 dysregulation in CAFs. ADH1B expression was downregulated in approximately 50% of studied tubular adenomas and all T1-4 colon tumors, but not in hyperplastic polyps. ADH1B metabolizes alcohols, including retinol (RO), and is involved in the generation of all-trans retinoic acid (atRA). LPS-induced IL-6 production was inhibited by either RO or its byproduct atRA in N-MFs, but only atRA was effective in CAFs. Silencing ADH1B in N-MFs significantly upregulated LPS-induced IL-6 similar to those observed in CAFs and lead to the loss of RO inhibitory effect on inducible IL-6 expression.
CONCLUSION: Our data identify ADH1B as a novel potential mesenchymal tumor suppressor, which plays a critical role in ADH1B/retinoid-mediated regulation of tumor-promoting IL-6.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:128 |
---|---|
Enthalten in: |
British journal of cancer - 128(2023), 4 vom: 08. Feb., Seite 537-548 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Villéger, Romain [VerfasserIn] |
---|
Links: |
---|
Themen: |
11103-57-4 |
---|
Anmerkungen: |
Date Completed 28.02.2023 Date Revised 12.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41416-022-02066-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM34994511X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM34994511X | ||
003 | DE-627 | ||
005 | 20231227131029.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41416-022-02066-0 |2 doi | |
028 | 5 | 2 | |a pubmed24n1225.xml |
035 | |a (DE-627)NLM34994511X | ||
035 | |a (NLM)36482184 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Villéger, Romain |e verfasserin |4 aut | |
245 | 1 | 0 | |a Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts |b contribution to the increase of tumor-promoting IL-6 in colon cancer |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.02.2023 | ||
500 | |a Date Revised 12.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature Limited. | ||
520 | |a BACKGROUND: Increases in IL-6 by cancer-associated fibroblasts (CAFs) contribute to colon cancer progression, but the mechanisms involved in the increase of this tumor-promoting cytokine are unknown. The aim of this study was to identify novel targets involved in the dysregulation of IL-6 expression by CAFs in colon cancer | ||
520 | |a METHODS: Colonic normal (N), hyperplastic, tubular adenoma, adenocarcinoma tissues, and tissue-derived myo-/fibroblasts (MFs) were used in these studies | ||
520 | |a RESULTS: Transcriptomic analysis demonstrated a striking decrease in alcohol dehydrogenase 1B (ADH1B) expression, a gene potentially involved in IL-6 dysregulation in CAFs. ADH1B expression was downregulated in approximately 50% of studied tubular adenomas and all T1-4 colon tumors, but not in hyperplastic polyps. ADH1B metabolizes alcohols, including retinol (RO), and is involved in the generation of all-trans retinoic acid (atRA). LPS-induced IL-6 production was inhibited by either RO or its byproduct atRA in N-MFs, but only atRA was effective in CAFs. Silencing ADH1B in N-MFs significantly upregulated LPS-induced IL-6 similar to those observed in CAFs and lead to the loss of RO inhibitory effect on inducible IL-6 expression | ||
520 | |a CONCLUSION: Our data identify ADH1B as a novel potential mesenchymal tumor suppressor, which plays a critical role in ADH1B/retinoid-mediated regulation of tumor-promoting IL-6 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Alcohol Dehydrogenase |2 NLM | |
650 | 7 | |a EC 1.1.1.1 |2 NLM | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Lipopolysaccharides |2 NLM | |
650 | 7 | |a Tretinoin |2 NLM | |
650 | 7 | |a 5688UTC01R |2 NLM | |
650 | 7 | |a Vitamin A |2 NLM | |
650 | 7 | |a 11103-57-4 |2 NLM | |
700 | 1 | |a Chulkina, Marina |e verfasserin |4 aut | |
700 | 1 | |a Mifflin, Randy C |e verfasserin |4 aut | |
700 | 1 | |a Markov, Nikolay S |e verfasserin |4 aut | |
700 | 1 | |a Trieu, Judy |e verfasserin |4 aut | |
700 | 1 | |a Sinha, Mala |e verfasserin |4 aut | |
700 | 1 | |a Johnson, Paul |e verfasserin |4 aut | |
700 | 1 | |a Saada, Jamal I |e verfasserin |4 aut | |
700 | 1 | |a Adegboyega, Patrick A |e verfasserin |4 aut | |
700 | 1 | |a Luxon, Bruce A |e verfasserin |4 aut | |
700 | 1 | |a Beswick, Ellen J |e verfasserin |4 aut | |
700 | 1 | |a Powell, Don W |e verfasserin |4 aut | |
700 | 1 | |a Pinchuk, Irina V |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d 1947 |g 128(2023), 4 vom: 08. Feb., Seite 537-548 |w (DE-627)NLM000027537 |x 1532-1827 |7 nnns |
773 | 1 | 8 | |g volume:128 |g year:2023 |g number:4 |g day:08 |g month:02 |g pages:537-548 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41416-022-02066-0 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 128 |j 2023 |e 4 |b 08 |c 02 |h 537-548 |